News | April 25, 2007

Cardiologist Launches New Heart Supplements

April 26, 2007 — Cardiologist Lee A. Surkin, M.D., FAAC, is set to launch a new line of cardiac nutritional supplements this July. He says the new Cardiac Wellness Supplements are designed to complement, not replace, standard cardiovascular disease prevention and treatment therapies.

"Simply put, I developed Cardiac Wellness Supplements out of necessity," said Dr. Surkin. "I believe in an integrative approach to the prevention and treatment of cardiovascular disease. That means traditional medical care, exercise, and basic nutrition. As my patients became more educated, they asked me for recommendations for supplements to help improve their nutrition. I wasn't able to find the right supplements to meet their needs, so I developed my own proprietary line of products that I am now bringing to a broader market."

"Supplements are a worrisome area for many physicians because in most cases there is a real lack of solid scientific data to support safety or outcome," said Dr. Surkin. "As I looked at products available in the marketplace, I found few suitable options. And of the products I was comfortable recommending, expense was almost always an obstacle. Now, with my Wellcor Products, I can comfortably recommend products that have data to support them and are cost-effective."

Dr. Surkin utilized his training in human nutrition and cardiology to develop Cardiac Wellness Supplements, focusing on ingredients that have substantial scientific data on safety, efficacy and dosage. The product line will include five products: Wellcor Defense -- Omega 3, Wellcor Energize -- Supreme Green Tea, Wellcor Guard -- Resveratrol / Quercitin, Wellcor Strength -- CoEnzyme Q10 / Hawthorn and Wellcor Control -- Alpha-Lipoic Acid / L- Carnitine.
For more information visit www.cardiacwellness.com.

Related Content

Abbott Initiates XIENCE Short DAPT Clinical Trial
News | Antiplatelet and Anticoagulation Therapies| August 03, 2017
Abbott recently announced the first patient has been enrolled in a clinical study evaluating the short-term use of...
Study Discovers Anticoagulant Drugs Are Being Prescribed Against Safety Advice
News | Antiplatelet and Anticoagulation Therapies| July 25, 2017
July 25, 2017 — A study by researchers at the University of Birmingham has shown that general practitioners (GPs) are
long-duration dual anti-platelet therapy (L-DAPT) compared to short-duration dual antiplatelet (S-DAPT) after DES stent implantation
News | Antiplatelet and Anticoagulation Therapies| July 12, 2017
June 12, 2017 — Researchers have evaluated the long-term efficacy and safety of long-duration dual anti-platelet ther
Sex-Specific Cardiovascular Drug Dosages Needed to Reduce Adverse Reactions in Women
News | Womens Healthcare| July 07, 2017
Sex-specific cardiovascular drug dosages are needed to reduce adverse reactions in women, according to a position paper...
Bayer Now Enrolling Patients for Global Pulmonary Arterial Hypertension Study
News | Hypertension| July 05, 2017
Bayer has enrolled the first patient in a global Phase IV study assessing the clinical effects of riociguat in patients...
FDA Grants Priority Review of Xarelto sNDA for 10 mg Dose
News | Antiplatelet and Anticoagulation Therapies| June 29, 2017
Janssen Research & Development LLC announced the U.S. Food and Drug Administration (FDA) accepted for Priority...
radial access, transradial access trial using anticoagulants
News | Radial Access| June 15, 2017
June 15, 2017 — In patients undergoing t...
Cost comparison between NOACs, novel oral anticoagulants
News | Antiplatelet and Anticoagulation Therapies| May 31, 2017
May 31, 2017 – The results from the first real-world, matched head-to-head study comparing all-cause healthcare costs
Data was positive from the Watchman Left Atrial Appendage Closure (LAAC) Device from the EWOLUTION registry
News | Atrial Fibrillation| May 30, 2017
May 30, 2017 — Data was positive for safety and efficacy rates of the Watchman Left Atrial Appendage Closure (LAAC) D
Statins Associated With Improved Heart Structure and Function
News | Pharmaceuticals| May 26, 2017
Statins are associated with improved heart structure and function, according to research presented at EuroCMR 2017, May...
Overlay Init